Encapsulation of drug molecules into Calix[n]arene Nanobaskets. Role of Aminocalix[n]arenes in biopharmaceutical field

Journal of Pharmaceutical Sciences

Volumn 102, Issue 10, 2013, Pages 3485-3512

  Ukhatskaya, Elena V ^a   Kurkov, Sergey V ^a   Matthews, Susan E ^b   Loftsson, Thorsteinn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Antiinfectives; Calixarene; Complexation; Excipients; Inclusion compounds; Interaction; Nanoparticles; Structure activity relationship; Surfactants

Indexed keywords

AMINO ACID; AMINOCALIXARENE; CALIXARENE; DNA; NITROGEN; QUATERNARY AMMONIUM DERIVATIVE; SULFONATOCALIX [4,6,8] ARENE DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CYTOTOXICITY; DRUG CONFORMATION; DRUG SOLUBILITY; DRUG SYNTHESIS; GENE TARGETING; GENE VECTOR; HUMAN; HYDRODYNAMICS; HYDROPHILICITY; NANOENCAPSULATION; NONHUMAN; PHYSICAL CHEMISTRY; SURFACE PROPERTY;

ANTIINFECTIVES; CALIXARENE; COMPLEXATION; EXCIPIENTS; INCLUSION COMPOUNDS; INTERACTION; NANOPARTICLES; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACTANTS;

AMINO ACIDS; CALIXARENES; HUMANS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; WATER;

EID: 84883890570     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23681     Document Type: Review

References (142)

1. Gallagher JF, Ferguson G, Boehmer V, Kraft D. 1994. Self inclusion in a calix[5]arene structure; structure of the cone conformer of a pentahydroxy-p-tert-butylcalix[5]arene. Acta Crystallogr Sect C Cryst Struct Commun C50(1):73-77.
2. Li HB, Chen YY, Gong SL. 2002. An interesting approach to bis-calix[5]arene analogue from calix[6]arene. Chin Chem Lett 13(3):205-206.
3. Martino M, Gaeta C, Gregoli L, Neri P. 2002. Regioselective intramolecular bridging of p-tert-butylcalix[7]arene. Tetrahedron Lett 43(52):9521-9525.
4. Gaeta C, Martino M, Neri P. 2006. Conformational templation in a singly bridged calix[7]arene derivative induced by alkali metal cations. Org Lett 8(20):4409-4412.
5. Ghera BB, Wu Q, Leydier A, Coleman AW. 2009. Para-acyl-calix[9]arenes: Synthesis and interfacial assembly. J Inclus Phenom Macrocycl Chem 64(3-4):367-371.
6. Shinkai S, Arimura T, Araki K, Kawabata H, Satoh H, Tsubaki T, Manabe O, Sunamoto J. 1989. Syntheses and aggregation properties of new water-soluble calixarenes. J Chem Soc Perkin Trans (11):2039-2045.
7. Da Silva E, Lazar AN, Coleman AW. 2004. Biopharmaceutical applications of calixarenes. J Drug Deliv Sci Technol 14(1):3-20.
8. Perret F, Lazar AN, Coleman AW. 2006. Biochemistry of the para-sulfonato-calix[n]arenes. Chem Commun (23):2425-2438.
9. Arduini A, Pochini A, Reverberi S, Ungaro R. 1984. p-tert-Butylcalix[4]arene tetracarboxylic acid. A water soluble calixarene in a cone structure. J Chem Soc Chem Commun (15):981-982.
10. Kalchenko VI, Visotsky MA, Shivanyuk AN, Pirozhenko VV, Markovsky LN. 1996. Synthesis and binding properties of phosphorus-containing calixarenes and calixresorcinarenes. Phosphorus Sulfur Silicon Relat Elements 109(1-4):513-516.
11. Shahgaldian P, Coleman AW, Kalchenko VI. 2001. Synthesis and properties of novel amphiphilic calix-[4]-arene derivatives. Tetrahedron Lett 42(4):577-579.
12. Ukhatskaya EV, Kurkov SV, Matthews SE, El Fagui A, Amiel C, Dalmas F, Loftsson T. 2010. Evaluation of a cationic calix[4]arene: Solubilization and self-aggregation ability. Int J Pharm 402(1-2):10-19.
13. Gutsche CD, Muthukrishnan R. 1978. Calixarenes. 1. Analysis of the product mixtures produced by the base-catalyzed condensation of formaldehyde with para-substituted phenols. J Org Chem 43(25):4905-4906.
14. Gutsche CD. 1983. Calixarenes. Acc Chem Res 16(5):161-170.
15. Gutsche CD, Iqbal M, Nam KS, See K, Alam I. 1988. Conformational and complexational characteristics of calixarenes. Pure Appl Chem 60(4):483-488.
16. Shinkai S, Tsubaki T, Sone T, Manabe O. 1985. A new synthesis of p-nitrocalix[6]arene. Tetrahedron Lett 26(28):3343-3344.
17. Shinkai S. 1986. Calixarenes as new functionalized host molecules. Pure Appl Chem 58(11):1523-1528.
18. Shinkai S. 1989. Molecular recognition of calixarene-based host molecules. J Inclus Phenom Mol Recogn Chem 7(2):193-201.
19. Nagasaki T, Sisido K, Arimura T, Shinkai S. 1992. Novel conformational isomerism of water-soluble calix[4]arenes. Tetrahedron 48(5):797-804.
20. Gutsche CD, Nam KC. 1988. Calixarenes. 22. Synthesis, properties, and metal complexation of aminocalixarenes. J Am Chem Soc 110(18):6153-6162.
21. Mbemba C, Sigaud K, Perret F, Suwinska K, Shkurenko O, Coleman AW. 2008. Calix[n]arenes as components for the construction of micellar systems: Synthesis and self-assembly properties of 5, 11, 17-Tris[(dimethylamino)methyl]-25-monoalkoxy-26, 27, 28-trihydroxycalix[4]arene derivatives. J Inclus Phenom Macrocycl Chem 61(1-2):29-40.
22. Lee M, Lee S-J, Jiang L-H 2004. Stimuli-responsive supramolecular nanocapsules from amphiphilic calixarene assembly. J Am Chem Soc 126(40):12724-12725.
23. Weeden C, Hartlieb KJ, Lim LY. 2012. Preparation and physicochemical characterization of a novel paclitaxel-loaded amphiphilic aminocalixarene nanoparticle platform for anticancer chemotherapy. J Pharm Pharmacol 64(10):1403-1411.
24. Shahgaldian P, Sciotti MA, Pieles U. 2008. Amino-substituted amphiphilic calixarenes: Self-assembly and interactions with DNA. Langmuir 24(16):8522-8526.
25. Dudic M, Colombo A, Sansone F, Casnati A, Donofrio G, Ungaro R. 2004. A general synthesis of water soluble upper rim calix[n]arene guanidinium derivatives which bind to plasmid DNA. Tetrahedron 60(50):11613-11618.
26. Sansone F, Dudic M, Donofrio G, Rivetti C, Baldini L, Casnati A, Cellai S, Ungaro R. 2006. DNA condensation and cell transfection properties of guanidinium calixarenes: Dependence on macrocycle lipophilicity, size, and conformation. J Am Chem Soc 128(45):14528-14536.
27. Martin OM, Yu L, Mecozzi S. 2005. Solution self-assembly and solid state properties of fluorinated amphiphilic calix[4]arenes. Chem Commun (39):4964-4966.
28. Bagnacani V, Sansone F, Donofrio G, Baldini L, Casnati A, Ungaro R. 2008. Macrocyclic nonviral vectors: High cell transfection efficiency and low toxicity in a lower rim guanidinium calix[4]arene. Org Lett 10(18):3953-3956.
29. Shinkai S. 1993. Calixarenes-The third generation of supramolecules. Tetrahedron 49(40):8933-8968.
30. Arimori S, Nagasaki T, Shinkai S. 1993. Tailor-making of desired assemblies from well-designed monomers: Use of calix[4]arene conformers as building blocks. J Chem Soc Perkin Trans (8):887-889.
31. Arimori S, Nagasaki T, Shinkai S. 1995. Self-assembly of tetracationic amphiphiles bearing a calix[4]arene core. Correlation between the core structure and the aggregation properties. J Chem Soc Perkin Trans (4):679-683.
32. Strobel M, Kita-Tokarczyk K, Taubert A, Vebert C, Heiney PA, Chami M, Meier W. 2006. Self-assembly of amphiphilic calix[4]arenes in aqueous solution. Adv Funct Mater 16(2):252-259.
33. Yang WC, Yu XD, Yu AM, Chen HY. 2001. Study of a novel cationic calix[4]arene used as selectivity modifier in capillary electrophoresis with electrochemical detection. J Chromatogr A 910(2):311-318.
34. Cherif JK, Mahouachi M, Abidi R, Vicens J. 2006. Synthesis and complexation studies of a tetra(N, N-dimethyl) aminoethylamide p-tert-butyl calix[4]arene and its tetramethylammonium derivative. J Inclus Phenom Macrocycl Chem 55(1-2):51-57.
35. Mchedlov-Petrossyan NO, Vodolazkaya NA, Rodik RV, Bogdanova LN, Cheipesh TA, Soboleva OY, Kryshtal AP, Kutuzova LV, Kalchenko VI. 2012. Colloidal nature of cationic calix[6]arene aqueous solutions. J Phys Chem C 116(18):10245-10259.
36. Rodik RV, Klymchenko AS, Jain N, Miroshnichenko SI, Richert L, Kalchenko VI, Mely Y. 2011. Virus-sized DNA nanoparticles for gene delivery based on micelles of cationic calixarenes. Chemistry 17(20):5526-5538.
37. Lalor R, DiGesso JL, Mueller A, Matthews SE. 2007. Efficient gene transfection with functionalized multicalixarenes. Chem Commun (46):4907-4909.
38. Ryu E-H, Zhao Y. 2005. Efficient synthesis of water-soluble calixarenes using click chemistry. Org Lett 7(6):1035-1037.
39. Bize C, Garrigues J-C, Blanzat M, Rico-Lattes I, Bistri O, Colasson B, Reinaud O. 2010. Spontaneous formation of vesicles in a catanionic association involving a head and tail functionalized amino-calix[6]arene. Chem Commun 46(4):586-588.
40. Fujii S, Sanada Y, Nishimura T, Akiba I, Sakurai K. 2012. A stimulus-responsive shape-persistent micelle bearing a calix[4]arene building block: Reversible pH-dependent transition between spherical and cylindrical forms. Langmuir 28(6):3092-3101.
41. Shinkai S, Araki K, Shibata J, Tsugawa D, Manabe O. 1989. Diazo coupling reactions with calix[4]arene. pKa Determination with chromophoric azocalix[4]arenes. Chem Lett (6):931-934.
42. Gutsche CD, Dhawan B, Levine JA, Kwang HN, Bauer LJ. 1983. Calixarenes. 9. Conformational isomers of the ethers and esters of calix[4]arenes. Tetrahedron 39(3):409-426.
43. Ukhatskaya E, Kurkov S, Matthews S, Loftsson T. 2013. Antifungal drug solubilizing activity and self-aggregation ability of cationic aminocalix[4]arene in comparison to SBEβCD: Effect of addition of water-soluble polymer. J Inclus Phenom Macrocycl Chem:1-9.
44. Mchedlov-Petrossyan NO, Vilkova LN, Vodolazkaya NA, Yakubovskaya AG, Rodik RV, Boyko VI, Kalchenko VI. 2006. The nature of aqueous solutions of a cationic calix[4]arene: A comparative study of dye-calixarene and dye-surfactant interactions. Sensors 6(8):962-977.
45. Cho EJ, Kang JK, Han WS, Jung JH. 2008. Stimuli-responsive supramolecular nanostructure from amphiphilic calix[4]arene and its three-dimensional dendritic silver nanostructure. Langmuir 24(10):5229-5232.
46. Gutsche CD, Rogers JS, Stewart D, See KA. 1990. Calixarenes: Paradoxes and paradigms in molecular baskets. Pure Appl Chem 62(3):485-491.
47. Iwamoto K, Araki K, Shinkai S. 1991. Syntheses of all possible conformational isomers of O-alkyl-p-tert-butylcalix[4]arenes. Tetrahedron 47(25):4325-4342.
48. Rehm M, Frank M, Schatz J. 2009. Water-soluble calixarenes-Self-aggregation and complexation of noncharged aromatic guests in buffered aqueous solution. Tetrahedron Lett 50(1):93-96.
49. Wang Y-X, Guo D-S, Cao Y, Liu Y. 2013. Phosphatase-responsive amphiphilic calixarene assembly. RSC Adv 3:8058-8063.
50. Mchedlov-Petrossyan NO, Vodolazkaya NA, Vilkova LN, Soboleva OY, Kutuzova LV, Rodik RV, Miroshnichenko SI, Drapaylo AB. 2009. The influence of cationic tetrapropoxycalix[4]arene choline on protolytic equilibria of acid-base indicators in aqueous solutions. J. Mol. Liquids 145(3):197-203.
51. Gutsche CD. 1998. Calixarenes Revisited. Cambridge, UK: Royal Society of Chemistry.
52. Sgarlata C, Bonaccorso C, Gulino FG, Zito V, Arena G, Sciotto D. 2009. Inclusion of aromatic and aliphatic anions into a cationic water-soluble calix[4]arene at different pH values. Tetrahedron Lett 50(14):1610-1613.
53. Casnati A, Sciotto D, Arena G. 2001. Water-soluble calixarenes. Asfari Z. et al. (Eds.) Calixarenes.Kluwer Academic Publishers. pp 440-456.
54. Zhang Y, Cao W. 2001. Self-assembly of small molecules: An approach combining electrostatic self-assembly technology with host-guest chemistry. New J Chem 25(3):483-486.
55. Zakharova LY, Kudryashova YR, Selivanova NM, Voronin MA, Ibragimova AR, Solovieva SE, Gubaidullin AT, Litvinov AI, Nizameev IR, Kadirov MK, Galyametdinov YG, Antipin IS, Konovalov AI. 2010. Novel membrane mimetic systems based on amphiphilic oxyethylated calix[4]arene: Aggregative and liquid crystalline behavior. J Membr Sci 364(1-2):90-101.
56. Lalor R, Baillie-Johnson H, Redshaw C, Matthews SE, Mueller A. 2008. Cellular uptake of a fluorescent calix[4]arene derivative. J Am Chem Soc 130(10):2892-2893.
57. Yang W, De Villiers MM 2004. The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[n]arenes. Eur J Pharm Biopharm 58(3):629-636.
58. Yang W, de Villiers MM. 2005. Effect of 4-sulfonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic. AAPS J 7(1):E241-E248.
59. Fanni S, Arnaud-Neu F, McKervey MA, Schwing-Weill M-J, Ziat K. 1996. Dramatic effects of p-dealkylation on the binding abilities of p-tert-butylcalix[6]arenes: New Cs+ and Sr2 +selective receptors. Tetrahedron Lett 37(44):7975-7978.
60. Schuehle DT, Klimosch S, Schatz J. 2008. Information transfer in calix[4]arenes: Influence of upper rim substitution on alkaline metal complexation at the lower rim. Tetrahedron Lett 49(40):5800-5803.
61. Beer PD, Drew MGB, Kan M, Leeson PB, Ogden MI, Williams G. 1996. Lanthanide structures, coordination, and extraction investigations of a 1, 3-bis(diethyl amide)-substituted calix[4]arene ligand. Inorg Chem 35(8):2202-2211.
62. Beer PD, Drew MGB, Leeson PB, Ogden MI. 1996. Metal complexes of a calix[4]arene diamide: Syntheses, crystal structures and molecular mechanics calculations on [Fe(L1-2H)][FeCl4] and [Er(L1-2H)(picrate)] (L1 = 5, 11, 17, 23-tetra-tert-butyl-25, 27-bis(diethylcarbamoylmethoxy)calix[4]arene). Inorg Chim Acta 246(1-2):133-141.
63. Jose P, Menon S. 2007. Lower-rim substituted calixarenes and their applications. Bioinorg Chem Appl 2007:65815.
64. Kalchenko VI. 2008. Calixarene receptors of environmentally hazardous and biorelevant molecules and ions. Pure Appl Chem 80(7):1449-1458.
65. Abraham W. 2002. Inclusion of organic cations by calix[n]arenes. J Inclus Phenom Macrocycl Chem 43(3-4):159-174.
66. Sliwa W, Girek T. 2010. Calixarene complexes with metal ions. J Inclus Phenom Macrocycl Chem 66(1):15-41.
67. Sidorov V, Kotch FW, Abdrakhmanova G, Mizani R, Fettinger JC, Davis JT. 2002. Ion channel formation from a calix[4]arene amide that binds HCl. J Am Chem Soc 124(10):2267-2278.
68. Sidorov V, Kotch FW, Kuebler JL, Lam Y-F, Davis JT. 2003. Chloride transport across lipid bilayers and transmembrane potential induction by an oligophenoxyacetamide. J Am Chem Soc 125(10):2840-2841.
69. Seganish JL, Santacroce PV, Salimian KJ, Fettinger JC, Zavalij P, Davis JT. 2006. Regulating supramolecular function in membranes: Calixarenes that enable or inhibit transmembrane Cl- transport. Angew. Chem. Int. Ed. 45(20):3334-3338.
70. Matthews SE, Beer PD. 2005. Calixarene-based anion receptors. Supramol Chem 17(6):411-435.
71. Kijima T, Ohe K, Shinkai S, Nagasaki T. 1992. Intercalation of a trimethylammoniomethylated calix[4]arene by copper(II)-montmorillonite. Bull Chem Soc Japan 65(9):2510-2513.
72. Bryant LH, Yordanov AT, Linnoila JJ, Brechbiel MW, Frank JA. 2000. First noncovalently bound calix[4]arene-GdIII-albumin complex. Angew. Chem. Int. Ed. 39(9):1641-1643.
73. Georgiev EM, Roundhill DM. 1997. An assessment of calixarene amides as potential magnetic resonance imaging enhancement agents for gadolinium(III). Inorg Chim Acta 258(1):93-96.
74. Wolf NJ, Georgiev EM, Yordanov AT, Whittlesey BR, Koch HF, Roundhill DM. 1999. Synthesis and crystal structures of lower rim amine and carbamoyl substituted calixarenes as transfer agents for oxyanions between an aqueous and a chloroform phase. Polyhedron 18(6):885-896.
75. Georgiev EM, Wolf N, Roundhill DM. 1997. Lower rim alkylammonium-substituted calix[4]arenes as "proton-switchable" extractants for chromate and dichromate anions. Polyhedron 16(9):1581-1584.
76. Dinares I, Garcia dM, Mesquida N, Alcalde E. 2009. Bis(imidazolium)-calix[4]arene receptors for anion binding. J Org Chem 74(1):482-485.
77. Kendi B, Naziroglu HN, Yilmaz M, Sirit A. 2010. Synthesis and anion binding properties of diamide derivatives of p-tert-butylcalix[4]arene. J Macromol Sci Part A Pure Appl Chem 47(3):225-229.
78. Baur M, Frank M, Schatz J, Schildbach F. 2001. Water-soluble calix[n]arenes as receptor molecules for non-polar substrates and inverse phase transfer catalysts. Tetrahedron 57(32):6985-6991.
79. Mchedlov-Petrossyan NO, Bogdanova LN, Rodik RV, Vodolazkaya NA, Kutuzova LV, Kalchenko VI. 2010. Aggregation of cationic calixarenes in water solutions and influence of their aggregates on the acid-base equilibrium of indicator dyes. Dopovidi Natsional'noi Akademii Nauk Ukraini (3):148-153.
80. Shimizu S, Kito K, Sasaki Y, Hirai C. 1997. Water-soluble calixarenes as new inverse phase-transfer catalysts. Nucleophilic substitution of alkyl and arylalkyl halides in aqueous media. Chem Commun (17):1629-1630.
81. Koner AL, Schatz J, Nau WM, Pischel U. 2007. Selective sensing of citrate by a supramolecular 1, 8-naphthalimide/calix[4]arene assembly via complexation-modulated pKa shifts in a ternary complex. J Org Chem 72(10):3889-3895.
82. Gale PA. 1998. Bis-amidinium calixarenes: Templates for self-assembled receptors. Tetrahedron Lett 39(22):3873-3876.
83. Darbost U, Giorgi M, Hucher N, Jabin I, Reinaud O. 2005. A calix[6]arene receptor rigidified by a self-assembled triammonium cap: X-ray and NMR characterization of the binding of polar neutral guests. Supramol Chem 17(3):243-250.
84. Darbost U, Zeng X, Giorgi M, Jabin I. 2005. Optically pure calix[6]tris-ammoniums: Syntheses and host-guest properties toward neutral guests. J Org Chem 70(25):10552-10560.
85. De Fatima A, Fernandes SA, Sabino AA. 2009. Calixarenes as new platforms for drug design. Curr Drug Discov Technol 6(2):151-170.
86. Shah MD, Agrawal YK. 2012. Calixarene: A new architecture in the analytical and pharmaceutical technology. J Sci Ind Res 71(1):21-26.
87. Mokhtari B, Pourabdollah K. 2012. Applications of calixarene nano-baskets in pharmacology. J Inclus Phenom Macrocycl Chem 73(1):1-15.
88. Parini C, Colombi S, Casnati A. 1994. Solid state interaction of steroids with calixarenes. I. A preliminary FTIR and DSC study on 4-en-3-keto-steroids. J Inclus Phenom Mol Recogn Chem 18(4):341-351.
89. Danylyuk O, Monachino M, Lazar AN, Suwinska K, Coleman AW. 2010. Conformational isomerism in the solid-state structures of tetracaine and tamoxifen with para-sulphonato-calix[4]arene. J Mol Struct 965(1-3):116-120.
90. Dupont N, Lazar AN, Perret F, Danylyuk O, Suwinska K, Navaza A, Coleman AW. 2008. Solid state structures of the complexes between the antiseptic chlorhexidine and three anionic derivatives of calix[4]arene. CrystEngComm 10(8):975-977.
91. Suwinska K, Coleman AW. 2008. Structure of the kanamycin-calix[4]arene di-O-phosphonate salt. CrystEngComm 10(10):1302-1304.
92. Li Q, Guo D-S, Qian H, Liu Y. 2012. Complexation of p-sulfonatocalixarenes with local anaesthetics guests: binding structures, stabilities, and thermodynamic origins. Eur J Org Chem (21):3962-3971, S3962/3961-S3962/3911.
93. Millership JS. 2001. A preliminary investigation of the solution complexation of 4-sulphonic calix[n]arenes with testosterone. J Inclus Phenom Macrocycl Chem 39(3-4):327-331.
94. Da Silva E, Valmalle C, Becchi M, Cuilleron C-Y, Coleman AW. 2003. The use of electrospray mass spectrometry (ES/MS) for the differential detection of some steroids as calix-[n]-arene sulphonate complexes. J Inclus Phenom Macrocycl Chem 46(1-2):65-69.
95. Yang W, Otto DP, Liebenberg W, de Villiers MM. 2008. Effect of para-sulfonato-calix[n]arenes on the solubility, chemical stability, and bioavailability of a water insoluble drug nifedipine. Curr Drug Discov Technol 5(2):129-139.
96. Yang W, de Villiers MM. 2006. Thermal analysis of supramolecular systems: Characterization of water-soluble, calixarene-drug complexes. Am Pharm Rev 9(4):70, 72-75.
97. Bayrakci M, Ertul S, Yilmaz M. 2012. Phase solubility studies of poorly soluble drug molecules by using O-phosphorylated calixarenes as drug-solubilizing agents. J Chem Eng Data 57(1):233-239.
98. Bayrakci M, Ertul S, Yilmaz M. 2012. Solubilizing effect of the p-phosphonate calix[n]arenes towards poorly soluble drug molecules such as nifedipine, niclosamide and furosemide. J Inclus Phenom Macrocycl Chem 74(1-4):415-423.
99. Yang W, De Villiers MM 2004. Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes. J Pharm Pharmacol 56(6):703-708.
100. Lu Q, Gu J, Yu H, Liu C, Wang L, Zhou Y. 2007. Study on the inclusion interaction of p-sulfonated calix[n]arenes with vitamin K3 using methylene blue as a spectral probe. Spectrochim Acta Part A Mol Biomol Spectrosc 68(1):15-20.
101. Zhou Y, Xu H, Wu L, Liu C, Lu Q, Wang L. 2008. Spectrofluorimetric study on the inclusion interaction between vitamin K3 with p-(p-sulfonated benzeneazo)calix[6]arene and determination of VK3. Spectrochim Acta Part A Mol Biomol Spectrosc 71A(2):597-602.
102. Song J, Li H, Chao J, Dong C, Shuang S. 2012. Spectroscopic studies on the inclusion interaction of p-sulfonatocalix[6]arene with vitamin B6. J Inclus Phenom Macrocycl Chem 72(3-4):389-395.
103. Lu Q, Zhou Y, Sun J, Wu L, Yu H, Xu H, Wang L. 2007. Preparation and property screening of the solid inclusion complex of norfloxacin with p-sulfonated calix[4]arene. Combinat Chem High Throughput Screen 10(6):480-485.
104. Wang X, Luo C, Lv Z, Lu F. 2011. Investigation of the inclusion behavior between p-sulfoniccalix[8]arene and norfloxacin by fluorescence spectroscopy. J Lumin 131(9):1986-1990.
105. Zhou Y, Xu H, Yu H, Chun L, Lu Q, Wang L. 2008. Spectrofluorometric study on the inclusion behavior of p-(p-carboxyl benzeneazo) calix[4]arene with norfloxacin. Spectrochim Acta Part A Mol Biomol Spectrosc 70A(2):411-415.
106. Zhou Y, Lu Q, Liu C, She S, Wang L. 2006. Spectrofluorimetric study on the inclusion interaction between lomefloxacin and p-sulfonated calix[4]arene and its analytical application. Spectrochim Acta Part A Mol Biomol Spectrosc 64A(3):748-756.
107. Zhou Y, Liu C, Yu H, Xu H, Lu Q, Wang L. 2006. A preliminary investigation of the complexation of dopamine by p-sulfonated calix[4, 6] arene and β-cyclodextrin using fluorescence spectrometry. Spectrosc Lett 39(5):409-420.
108. Fernandes SA, Cabeca LF, Marsaioli AJ, Paula E. 2007. Investigation of tetracaine complexation with beta-cyclodextrins and p-sulphonic acid calix[6]arenes by nOe and PGSE NMR. J Inclus Phenom Macrocycl Chem 57(1-4):395-401.
109. Arantes LM, Scarelli C, Marsaioli AJ, de Paula E, Fernandes SA. 2009. Proparacaine complexation with β-cyclodextrin and p-sulfonic acid calix[6]arene, as evaluated by varied 1H-NMR approaches. Magn Reson Chem 47(9):757-763.
110. Panchal JG, Patel RV, Menon SK. 2010. Preparation and physicochemical characterization of carbamazepine (CBMZ): Para-sulfonated calix[n]arene inclusion complexes. J Inclus Phenom Macrocycl Chem 67(1-2):201-208.
111. Menon S, Mistry B, Joshi K, Modi N, Shashtri D. 2012. Evaluation and solubility improvement of Carvedilol: PSC[n]arene inclusion complexes with acute oral toxicity studies. J Inclus Phenom Macrocycl Chem 73(1):295-303.
112. Megyesi M, Biczok L. 2006. Considerable fluorescence enhancement upon supramolecular complex formation between berberine and p-sulfonated calixarenes. Chem Phys Lett 424(1-3):71-76.
113. de Assis JV, Teixeira MG, Soares CGP, Lopes JF, Carvalho GSL, Lourenco MCS, de Almeida MV, Fernandes SA. 2012. Experimental and theoretical NMR determination of isoniazid and sodium p-sulfonatocalix[n]arenes inclusion complexes. Eur J Pharm Sci 47(3):539-548.
114. Wang G-S, Zhang H-Y, Ding F, Liu Y. 2011. Preparation and characterization of inclusion complexes of topotecan with sulfonatocalixarene. J Inclus Phenom Macrocycl Chem 69(1):85-89.
115. Wang K, Guo D-S, Wang X, Liu Y. 2011. Multistimuli responsive supramolecular vesicles based on the recognition of p-sulfonatocalixarene and its controllable release of doxorubicin. ACS Nano 5(4):2880-2894.
116. Menon SK, Jose P, Harikrishnan U, Pal U. 2008. Calix[6]arene derivative as chromogenic sensor for anti-hypertensive drugs. Indian J Chem Sect A 47A(2):246-250.
117. Menon SK, Modi NR, Mistry B, Joshi K. 2011. Improvement of some pharmaceutical properties of mycophenolate mofetil (MMF) by para sulphonatocalix[4]resorcinarene inclusion complex. J Inclus Phenom Macrocycl Chem 70(1-2):121-128.
118. Chamseddin C, Jira T. 2013. Complexation of achiral calixarenes with chiral pharmaceutical substances: A circular dichroism study. Curr Pharm Anal 9(1):121-129.
119. Xue Y, Guan Y, Zheng A, Xiao H. 2013. Amphoteric calix[8]arene-based complex for pH-triggered drug delivery. Colloids Surf B 101:55-60.
120. Consoli GML, Granata G, Geraci C. 2011. Design, synthesis, and drug solubilising properties of the first folate-calix[4]arene conjugate. Org Biomol Chem 9(19):6491-6495.
121. Da Silva E, Shahgaldian P, Coleman AW. 2004. Hemolytic properties of some water-soluble para-sulfonato-calix-[n]-arenes. Int J Pharm 273(1-2):57-62.
122. Paclet M-H, Rousseau CF, Yannick C, Morel F, Coleman AW. 2006. An absence of non-specific immune response towards para-sulphonato-calix[n]arenes. J Inclus Phenom Macrocycl Chem 55(3-4):353-357.
123. Higler I, Timmerman P, Verboom W, Reinhoudt DN. 1996. Combination of calix[4]arenes and resorcin[4]arenes for the complexation of steroids. J Org Chem 61(17):5920-5931.
124. Higler I, Verboom W, van Veggel FCJM, De Jong F, Reinhoudt DN. 1997. Complexation properties of preorganized receptor molecules for large neutral guests. Liebigs Annalen/Recueil (7):1577-1586.
125. Coleman AW, Perret F, Moussa A, Dupin M, Guo Y, Perron H. 2007. Calix[n]arenes as protein sensors. Top Curr Chem 277(Creative Chemical Sensor Systems):31-88.
126. Rodik RV, Boyko VI, Kalchenko VI. 2009. Calixarenes in bio-medical researches. Curr Med Chem 16(13):1630-1655.
127. Mecca T, Cunsolo F. 2007. Calix[4]arene-based ligands as endotoxin receptors. Tetrahedron 63(44):10764-10767.
128. Mourer M, Duval RE, Finance C, Regnouf-de-Vains J-B. 2006. Functional organization and gain of activity: The case of the antibacterial tetra-para-guanidinoethyl-calix[4]arene. Bioorg Med Chem Lett 16(11):2960-2963.
129. Grare M, Mourer M, Fontanay S, Regnouf-de-Vains J-B, Finance C, Duval RE. 2007. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. J Antimicrob Chemother 60(3):575-581.
130. Grare M, Dibama HM, Lafosse S, Ribon A, Mourer M, Regnouf-de-Vains JB, Finance C, Duval RE. 2010. Cationic compounds with activity against multidrug-resistant bacteria: Interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect 16(5):432-438.
131. Mourer M, Dibama HM, Fontanay S, Grare M, Duval RE, Finance C, Regnouf-de-Vains J-B. 2009. p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation. Bioorg Med Chem 17(15):5496-5509.
132. Dibama HM, Clarot I, Fontanay S, Salem AB, Mourer M, Finance C, Duval RE, Regnouf-de-Vains J-B. 2009. Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct. Bioorg Med Chem Lett 19(10):2679-2682.
133. Casnati A, Fabbi M, Pelizzi N, Pochini A, Sansone F, Ungaro R. 1996. Synthesis, antimicrobial activity and binding properties of calix[4]arene based vancomycin mimics. Bioorg Med Chem Lett 6(22):2699-2704.
134. Lamartine R, Tsukada M, Wilson D, Shirata A. 2002. Antimicrobial activity of calixarenes. Comptes Rendus Chimie 5(3):163-169.
135. Motornaya AE, Alimbarova LM, Shokova EA, Kovalev VV. 2006. Synthesis and antiherpetic activity of N-(3-amino-1-adamantyl)calix[4]arenes. Pharm Chem J 40(2):68-72.
136. Da Silva E, Coleman AW. 2003. Synthesis and complexation properties towards amino acids of mono-substituted p-sulphonato-calix-[n]-arenes. Tetrahedron 59(37):7357-7364.
137. Da Silva E, Rousseau CF, Zanella-Cleon I, Becchi M, Coleman AW. 2006. Mass spectrometric determination of association constants of bovine serum albumin (BSA) with para-sulfonato-calix[n]arene derivatives. J Inclus Phenom Macrocycl Chem 54(1-2):53-59.
138. Zadmard R, Schrader T. 2005. Nanomolar protein sensing with embedded receptor molecules. J Am Chem Soc 127(3):904-915.
139. Mecca T, Consoli GML, Geraci C, Cunsolo F. 2004. Designed calix[8]arene-based ligands for selective tryptase surface recognition. Bioorg Med Chem 12(19):5057-5062.
140. Da Silva E, Ficheux D, Coleman AW. 2005. Anti-thrombotic activity of water-soluble calix[n]arenes. J Inclus Phenom Macrocycl Chem 52(3-4):201-206.
141. Shi Y, Schneider H-J 1999. Interactions between aminocalixarenes and nucleotides or nucleic acids. J Chem Soc Perkin Trans 2 Phys Org Chem (8):1797-1803.
142. Pires VS, Gaboriau F, Guillon J, Da Nascimento S, Dassonville A, Lescoat G, Desplat V, Rochette J, Jarry C, Sonnet P. 2006. Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes. J Enzyme Inhib Med Chem 21(3):261-270.